Kite Pharma, Inc. Stock-Based Compensation
Kite Pharma, Inc. reported Stock-Based Compensation of $49.24 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2017-08-08
- Kite Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-06-30 was $25.16M, a 27.37% increase year-over-year.
- Kite Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-03-31 was $24.08M, a 61.98% increase year-over-year.
- Kite Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2016-12-31 was $19.70M, a 45.69% increase year-over-year.
- Kite Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2016-09-30 was $19.26M, a 77.63% increase year-over-year.
- Kite Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $73.58M, a 82.04% increase from fiscal 2015.
- Kite Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2015 was $40.42M, a 150.36% increase from fiscal 2014.
- Kite Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2014 was $16.14M, a 12816.00% increase from fiscal 2013.
- Kite Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2013 was $125.00K, a 316.67% increase from fiscal 2012.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2017-06-30 | $25.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $49.24M 10-Q · filed 2017-08-08 | $68.94M derived: sum of 3 quarters · filed 2017-08-08 | $88.20M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | $24.08M 10-Q · filed 2017-05-08 | $43.77M derived: sum of 2 quarters · filed 2017-05-08 | $63.03M derived: sum of 3 quarters · filed 2017-05-08 | $82.79M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-12-31 | $19.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $38.96M derived: sum of 2 quarters · filed 2017-02-28 | $58.72M derived: sum of 3 quarters · filed 2017-08-08 | $73.58M 10-K · filed 2017-02-28 |
| 2016-09-30 | $19.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $39.02M derived: sum of 2 quarters · filed 2017-08-08 | $53.88M 10-Q · filed 2016-11-09 | $67.40M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-06-30 | $19.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $34.62M 10-Q · filed 2017-08-08 | $48.14M derived: sum of 3 quarters · filed 2017-08-08 | $58.98M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $14.86M 10-Q · filed 2017-05-08 | $28.38M derived: sum of 2 quarters · filed 2017-05-08 | $39.23M derived: sum of 3 quarters · filed 2017-05-08 | $48.61M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | $13.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $24.36M derived: sum of 2 quarters · filed 2017-02-28 | $33.74M derived: sum of 3 quarters · filed 2017-02-28 | $40.42M 10-K · filed 2017-02-28 |
| 2015-09-30 | $10.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $20.23M derived: sum of 2 quarters · filed 2016-11-09 | $26.90M 10-Q · filed 2016-11-09 | $32.41M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $9.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $16.06M 10-Q · filed 2016-08-08 | $21.57M derived: sum of 3 quarters · filed 2017-02-28 | $24.96M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $6.68M 10-Q · filed 2016-05-09 | $12.19M derived: sum of 2 quarters · filed 2017-02-28 | $15.58M derived: sum of 3 quarters · filed 2017-02-28 | $22.63M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $8.90M derived: sum of 2 quarters · filed 2017-02-28 | $15.95M derived: sum of 3 quarters · filed 2017-02-28 | $16.14M 10-K · filed 2017-02-28 |
| 2014-09-30 | $3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $10.44M derived: sum of 2 quarters · filed 2015-11-12 | $10.63M 10-Q · filed 2015-11-12 | $10.72M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $7.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $7.24M 10-Q · filed 2015-08-10 | $7.33M derived: sum of 3 quarters · filed 2016-02-29 | $7.34M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $197.00K 10-Q · filed 2015-05-15 | $281.00K derived: sum of 2 quarters · filed 2016-02-29 | $292.00K derived: sum of 3 quarters · filed 2016-02-29 | |
| 2013-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $95.00K derived: sum of 2 quarters · filed 2016-02-29 | $125.00K 10-K · filed 2016-02-29 | |
| 2013-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $41.00K 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $30.00K 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $30.00K 10-K · filed 2015-03-26 |